30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mikael Dolsten

Track

Insider profile

Currently holds positions in Pfizer Inc and Karyopharm Therapeutics Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
31 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer, President - Worldwide Research, Development and Medical Pfizer Inc Jan. 1, 2019 -
Independent Director Karyopharm Therapeutics Inc Jan. 1, 2017 -
President - Worldwide Research and Development Pfizer Inc Dec. 1, 2010 - Jan. 1, 2019
Director Karyopharm Therapeutics Inc March 31, 2015 - Jan. 1, 2017
Mikael Dolsten's trades of Agilent Technologies Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-05-29
S Sale
54,453 -2.2%
478.48
US$1,401,575 		54,453 -2.2% 478.48 US$1,401,575
2026-05-29 2026-05-29
PrS Proposed sale
72,367
162.26
US$2,530,589 		72,367 162.26 US$2,530,589
2025-12-03 2025-12-01
S Sale
42,899 -39.8%
15.19
US$3,203,675 		42,899 -39.8% 15.19 US$3,203,675
2025-12-01 2025-12-01
PrS Proposed sale
2,600
149.81
US$389,510 		2,600 149.81 US$389,510
2025-05-23 2025-05-23
US Pfizer Inc (PFE)
PrS Proposed sale
59,781
23.09
US$1,380,632 		59,781 23.09 US$1,380,632
2025-05-05 2025-05-05
US Pfizer Inc (PFE)
PrS Proposed sale
55,000
23.87
US$1,312,736 		55,000 23.87 US$1,312,736
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
32,015 -8.8%
49.31
US$1,578,660 		32,015 -8.8% 49.31 US$1,578,660
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
18,562 -4.8%
49.32
US$915,478 		18,562 -4.8% 49.32 US$915,478
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
7,876 -2.0%
49.33
US$388,523 		7,876 -2.0% 49.33 US$388,523
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
2,891 -0.7%
49.35
US$142,671 		2,891 -0.7% 49.35 US$142,671
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
2,358 -0.6%
49.34
US$116,344 		2,358 -0.6% 49.34 US$116,344
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
200 -0.1%
49.36
US$9,872 		200 -0.1% 49.36 US$9,872
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
36,711 -11.6%
50.28
US$1,845,829 		36,711 -11.6% 50.28 US$1,845,829
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
6,708 -2.1%
50.33
US$337,614 		6,708 -2.1% 50.33 US$337,614
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
5,227 -1.6%
50.29
US$262,866 		5,227 -1.6% 50.29 US$262,866
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
3,396 -1.0%
50.31
US$170,853 		3,396 -1.0% 50.31 US$170,853
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
3,197 -1.0%
50.29
US$160,777 		3,197 -1.0% 50.29 US$160,777
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
2,301 -0.7%
50.32
US$115,786 		2,301 -0.7% 50.32 US$115,786
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
2,124 -0.6%
50.34
US$106,922 		2,124 -0.6% 50.34 US$106,922
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
24,242 -12.2%
37.79
US$916,105 		24,242 -12.2% 37.79 US$916,105
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
17,357 -8.0%
37.78
US$655,747 		17,357 -8.0% 37.78 US$655,747
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
16,840 -7.2%
37.80
US$636,552 		16,840 -7.2% 37.80 US$636,552
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
14,727 -5.9%
37.77
US$556,239 		14,727 -5.9% 37.77 US$556,239
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
9,700 -3.8%
37.75
US$366,175 		9,700 -3.8% 37.75 US$366,175
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
6,470 -2.4%
37.81
US$244,631 		6,470 -2.4% 37.81 US$244,631
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
5,517 -2.0%
37.76
US$208,322 		5,517 -2.0% 37.76 US$208,322
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
500 -0.2%
37.82
US$18,910 		500 -0.2% 37.82 US$18,910
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
38,645 -11.8%
43.52
US$1,681,830 		38,645 -11.8% 43.52 US$1,681,830
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
3,250 -1.0%
43.53
US$141,472 		3,250 -1.0% 43.53 US$141,472
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,600 -0.8%
43.54
US$113,204 		2,600 -0.8% 43.54 US$113,204
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,400 -0.7%
43.55
US$104,520 		2,400 -0.7% 43.55 US$104,520
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,187 -0.6%
43.56
US$95,266 		2,187 -0.6% 43.56 US$95,266
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
77,484 -18.6%
43.56
US$3,375,203 		77,484 -18.6% 43.56 US$3,375,203
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
14,760 -3.4%
43.57
US$643,093 		14,760 -3.4% 43.57 US$643,093
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
5,927 -1.4%
43.58
US$258,299 		5,927 -1.4% 43.58 US$258,299
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
2,300 -0.5%
43.59
US$100,257 		2,300 -0.5% 43.59 US$100,257